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Abstract
The slow growth ofMycobacterium tuberculosis (Mtb), the causative agent of tuberculosis
(TB), hinders development of new diagnostics, therapeutics and vaccines. Using non-inva-
sive real-time imaging technologies to monitor the disease process in live animals would
facilitate TB research in all areas. We developed fluorescent protein (FP) expressingMyco-
bacterium bovis BCG strains for in vivo imaging, which can be used to track bacterial loca-
tion, and to quantify bacterial load in live animals. We selected an optimal FP for in vivo
imaging, by first cloning six FPs: tdTomato, mCherry, mPlum, mKate, Katushka and
mKeima, into mycobacteria under either a mycobacterial Hsp60 or L5 promoter, and com-
pared their fluorescent signals in vitro and in vivo. Fluorescence from each FP-expressing
strain was measured with a multimode reader using the optimal excitation and emission
wavelengths for the FP. After normalizing bacterial numbers with optical density, the strain
expressing L5-tdTomato displayed the highest fluorescence. We used the tdTomato-
labeledM. bovis BCG to obtain real-time images of pulmonary infections in living mice and
rapidly determined the number of bacteria present. Further comparison between L5-tdTo-
mato and Hsp60-tdTomato revealed that L5-tdTomato carried four-fold more tdTomato
gene copies than Hsp60-tdTomato, which eventually led to higher protein expression of
tdTomato. Evaluating anti-TB efficacy of rifampicin and isoniazid therapy in vitro and in vivo
using the L5-tdTomato strain demonstrated that this strain can be used to identify anti-TB
therapeutic efficacy as quickly as 24 h post-treatment. TheseM. bovis BCG reporter strains
represent a valuable new tool for evaluation of therapeutics, vaccines and virulence.
Introduction
Tuberculosis (TB) is a major cause of morbidity and mortality worldwide [1]. The challenges
faced in TB control are: lack of an effective vaccine, emergence of multidrug-resistant TB glob-
ally, and increasing cases ofMycobacterium tuberculosis and HIV co-infection in many regions
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The causative agent of TB,M. tuberculosis, grows very slowly in culture. It takes weeks to
obtain visible colonies on agar plates to determine colony forming units (CFU) after inocula-
tion. Using non-invasive real-time optical imaging technologies to monitor the bacterial bur-
den and disease progress in small animals would greatly accelerate research in TB. When in
vivo optical imaging is used to estimate bacterial number, the bacteria within the site of infec-
tion can be quantified immediately based on the level of fluorescent or bioluminescent signal
they produce, rather than waiting for CFU, a tedious procedure that requires weeks to obtain
data.
Optical imaging systems have been successfully used in real-time monitoring of tumorigen-
esis and a growing number of infectious diseases [4–11]. Both bioluminescent imaging and
fluorescent imaging probes have been developed for TB research [10–19], a number of which
have been applied to in vivo imaging ofM. tuberculosis [11, 12, 14, 18, 19]. Fluorescent proteins
(FPs) have been used widely in cell and animal imaging to track cellular movement in embryo-
genesis and inflammatory processes [20, 21], to monitor pathogen migration in host [22–24],
and to study carcinogenesis processes in live animals [4, 25–28]. Imaging fluorescent signals in
deep tissues of animals requires that the FP has excitation and emission wavelengths within or
at least close to the near-infrared (NIR) window, which is 600–900 nm, because hemoglobin
and water have their lowest absorption coefficients in the NIR window [29]. Several FPs have
excitation and emission wavelengths close to this NIR window, with red or far-red colors rang-
ing from 581 nm to 655 nm [30].
After carefully comparing excitation and emission wavelengths, brightness, and photostabil-
ity, we selected mPlum [31], mKate, Katushka [28], Keima [32], mCherry, and tdTomato [33]
to clone into mycobacterial strains, and evaluate their sensitivity for detecting mycobacteria in
vitro and in vivo, using a multi-mode spectrometer and whole animal imaging system, IVIS
(PerkinElmer, Waltham, MA). The FP expressing strain having the highest sensitivity of detec-
tion was successfully applied to evaluation of the efficacy of anti-TB therapy in bacterial culture
and in live animals.
Materials and Methods
Plasmid Construction
The plasmids carrying tdTomato, mCherry and mPlum genes (pRSETB-tdTomato, pRSETB-
mCherry, and pBAD-mPlum) were acquired from Dr. Rodger Y. Tsien’s laboratory.
pmKeima-Red-S1 was from Amalgaam Co.; pTagFP635-C mKate and pTurboFP635-C
Katushka were purchased from Evrogen Co. To construct plasmids expressing tdTomato or
mCherry under Hsp60 promoter, pRSETB-tdTomato or pRSETB-mCherry DNA was cut with
NheI and ScaI. After gel purification to separate the DNA sequences containing tdTomato or
mCherry, the DNA fragments were ligated into the NheI / ScaI cut linear fragment of the
Escherichia coli-mycobacterium shuttle plasmid pJDC89 [34] that carries the Hsp60 promoter
to generate pJDC122 (Hsp60-tdTomato) or pJDC124 (Hsp60-mCherry). To construct plas-
mids expressing mPlum, Keima, mKate or mKatushika under Hsp60 promoter, these four FP
genes were amplified with PCR using an up-stream primer containing NheI site at 5’ end and a
down-stream primer containing PacI site at 5’ end. The PCR products were then cut with NheI
/ PacI, and ligated with the NheI / PacI digested linear fragment of the pJDC89 to generate
pJDC128 (Hsp60-mPlum), pJDC140 (Hsp60-Keima), pJDC130 (Hsp60-mKate), and pJDC131
(Hsp60-Katushka). The plasmids constructed and primers used for PCR are listed in Table 1.
To construct the plasmids expressing tdTomato or mCherry under the mycobacterial phage
L5 promoter, we first PCR amplified the two genes from pRSETB-tdTomato or pRSETB-
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mCherry using an up-stream primer containingHindIII site at 5’ end and a down-stream
primer containing KpnI site at 5’ end (Table 1). The primer pair was the same for both genes,
because tdTomato is a tandem dimer of mCherry. We then cut pFJS8, an E. coli-mycobacte-
rium shuttle plasmid containing the L5 promoter [35], withHindIII / KpnI, and separated the
larger fragment by gel purification. TheHindIII / KpnI digested PCR products were also gel
purified to get tdTomato and mCherry specific fragments, and then ligated into thisHindIII /
KpnI cut pFJS8 linear fragment, to form pJDC60 (L5-tdTomato) or pJDC171 (L5-mCherry).
Strains and Growth Conditions
Plasmids were transformed intoM. smegmatis andM. bovis BCG. Bacteria were grown in 7H9
broth (Difco, Detroit, MI) supplemented with 0.5% glycerol, 10% OAD (oleic acid dextrose
complex without catalase) and 0.05% Tween 80 (M-OADTW broth), or Middlebrook 7H9
supplemented with 10% OAD and 15 g/l Bacto agar (M-OAD agar, Difco) or on 7H11 selective
agar (Difco). When necessary, media and plates were supplemented with 80 μg/ml hygromycin
or 25 μg/ml kanamycin. Frozen stocks were prepared from strains for experiments by growth
standing at 37°C until an OD600 = 0.5 and stored in aliquots at -80°C until use.
Real-time qPCR
Reverse transcription was carried out with the SuperScript First-Strand Synthesis System for
RT-PCR based on Invitrogen’s protocol. Briefly, RNA/primer mixture in each tube was pre-
pared as: total RNA 150 ng, random hexamers (150 ng/ul) 1 ul, 1.25 mM dNTP mix 8 μl, and
adding DEPC H2O to 12 μl. The samples were incubated at 65°C for 5 min and then on ice for
at least 1 min. Reaction master mixture was prepared as: 5x RT buffer 4 μl, 0.1 M DTT 2 μl,
and RNAaseOUT 1 μl. The reaction mixture was added to the RNA/primer mixture, mix
briefly, and then place at 37°C for 2 min. One μl (10,000 units) of Super Script III RT was
added to each tube, mixed and incubated at 25°C for 10 min. The tubes were then incubated at
37°C for 50 min, heat inactivated at 70°C for 15 min, and then chilled on ice. One μl RNase H
was added into the tubes and tubes were incubated at 37°C for 20 min. The first strand cDNA
was stored at -20°C until use for real-time PCR. For real-time qPCR, each primer (forward or
reverse) concentration in the mixture was 12.5 pmol/μl. 0.4 μl of each primer, Supermix 10 μl,
Rox 25 uM 0.4 μl, cDNA or DNA template 2 μl, and H2O were mixed in a total 20 μl volume.
Real time qPCR was set up following PCR program on StepOnePlus™ Real-Time PCR System
Table 1. Plasmids and primers.
FP Plasmids Primers
tdTomato pJDC122 F: 5’- TATAAAGCTTGGATCCATGGTGAGCAAGG-3’
pJDC60 R: 5’-TATAGGTACCGAATTCTTACTTGTACAGCTCGTCC-3’
mCherry pJDC124 F: 5’- TATAAAGCTTGGATCCATGGTGAGCAAGG-3’
pJDC171 R: 5’-TATAGGTACCGAATTCTTACTTGTACAGCTCGTCC-3’
mPlum pJDC128 F: 5’- TATAGCTAGCGCCACCATGGTGAGCAA-3’
R: 5’-TATATTAATTAATAGGCGCCGGTGGAGT-3’
mKate pJDC130 F: 5’-TATAGCTAGCATGGTGTCTAAGGGCGAAGA-3’
R: 5’-TATATTAATTAAATTAAGTTTGTGCCCCAGTTTG-3’
Katushka pJDC121 F: 5’-TATAGCTAGCCCATGGTGGGTGAGGATAG-3’
R: 5’-TATATTAATTAAGCTGTGCCCCAGTTTGCTAG-3’
Keima pJDC140 F: 5’-TATAGCTAGCCATGGTGAGTGTGATCGCTAA-3’
R: 5’-TATATTAATTAAGTTAACCGAGCAAAGAGTGGC-3’
doi:10.1371/journal.pone.0149972.t001
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as: 1) 50°C 2 min, 1 cycle; 2) 95°C 2 min, 1 cycle; 3) 95°C 15 s and then 60°C 1 min, 40 cycles to
measure the fluorescence. Following the last cycle, the instrument generated a melting curve by
ramping from 60°C to 95°C at 0.2°C/s and continuously measuring the fluorescence. 4) 95°C
15 s; and 5) 60°C 1 min, 95°C 15 s, 1 cycle. 16s rRNA was used as an internal control. Primer
sequences for tdTomato: F: 5’-CAAGCTGAAGGTGACCAAGG-3’; R: 5’-GTGATGAACTTC
GAGGACGG-3’. Primer sequences for 16s rRNA: F: 5’-CCGCAAGRCTAAAACTCAAA-3’;
R: 5’-TGCACACAGGCCACAAGGGA-3’. Reactions with amplification cycle threshold values
of between 20 and 35 were considered successful and were analyzed with DNA melting curves.
Macrophage Infection Assays
The murine macrophage cell line J774A.1 (ATCC TIB67) was maintained at 37°C and 5% CO2
in high glucose Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Bethesda, MD) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS, Gibco) and 2 mM L-glutamine.
J774A.1 cells were infected in a similar manner to that described previously [36]. J774A.1 cells
were seeded at 2.5x105 cells/well in 24-well tissue culture plates or 1x105 cells/well in 8-well
chamber slides and incubated overnight at 37°C in DMEM. The media was then replaced just
prior to infection with 0.2 ml of media that contains 2.5 x 106 bacteria, equivalent to a multi-
plicity of infection (MOI) of approximately 10 (bacteria/cell). The bacteria were incubated with
the cells for 30 min at 37°C and washed twice with warm PBS, then the infected cells were incu-
bated with DMEM plus 10% FBS and 200 μg/ml amikacin for 2 h at 37°C. The cells in a tripli-
cate set of wells were then prepared for microscopy or entry assays.
Mouse Infections
All animal experiments in this study were approved by Texas A&M University Institutional
Animal Care and Use Committee. Five to seven week old female BALB/c mice were obtained
from Jackson Laboratories. All animals were housed in polycarbonate microisolator cages in a
controlled environment with 12h light / 12h dark cycle, ~18–23°C, and 40–60% humidity.
There were four animals in each experimental group. Animals were assigned randomly to
experimental groups, allowed to acclimate to the facilities for one week and fed commercial
chow with low chlorophyll content and tap water ad libitum. Portions of lungs were homoge-
nized in PBS, and dilutions were plated on 7H11 selective media to determine numbers of bac-
teria present at each time point. Sub-cutaneous infections were carried out by suspending the
appropriate concentration of bacteria in 50 μl of saline prior to inoculation directly beneath the
skin. Bacterial numbers were confirmed at 24 h post-inoculation by harvesting the region of
the skin and homogenization in PBS followed by dilution and plating on 7H11 selective media
to determine the colony forming units present. Alternatively, mice were infected intratracheally
withM. bovis BCG, as described previously [37, 38]. Briefly, mice were anesthetized with keta-
mine and xylazine mixture by intraperitoneal injection, and were put in a ventral position on a
stand. The mouse tongue was pull out of the mouth with a forceps. After seeing the larynx
opening with an otoscope, a catheter with the guide wire running through was carefully placed
into the larynx. The guide wire was then removed, and 50 μl of bacteria in saline was pipetted
into the hub of the catheter. The bacteria were then flushed into lungs with 50 μl of air from a 1
ml syringe. Four mice per group were imaged and sacrificed for necropsy to determine thresh-
olds of detection. Antibiotic treatment was carried out with four mice per group, randomly
allocated, by administration of RIF plus INH intraperitoneally daily at 10 mg kg−1 animal body
weight. At each time point a group of animals in each treatment category were imaged, necrop-
sied, lungs imaged and homogenized for CFU determination by plating dilutions of tissue
homogenates. Each experiment was independently performed twice.
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Imaging Tuberculosis Infections
Mice were anesthetized with isofluorane and imaged in an IVIS Spectrum (Caliper Life Sci-
ences) with and without filters for fluorescence. Photographic images were directly overlaid
with matching fluorescent images for all mice. Structural images were taken in all cases where
fluorescence molecular tomography was used. Wavelength-resolved spectral imaging was car-
ried out to image fluorescent protein-expressing BCG in mice. In the case of tdTomato, the
excitation wavelength was 535 nm and emission was collected in 20 nm increments from 540
nm to 660 nm; for mCherry the excitation wavelength was 570 nm and emission was collected
in 20 nm increments from 580 nm to 680 nm. Each acquisition was taken for 2–4 s with f-stop
one and medium binning. Images were analyzed with Living Image Software v4.1 using spec-
tral unmixing algorithms to remove autofluorescence, as described by the provider, with one of
the resulting channels locked to fit the emission spectrum of the appropriate fluorophore
(tdTomato or mCherry).
Confocal Fluorescent Microscopy
J774 A.1 cell infection. Cells were seeded in 8-well chamber slides with 1 x 105 cells per
well in 200 μl of DMEM plus 10%FBS overnight at 37°C in 5% CO2. The medium was removed
and the tdTomato expressingM. bovis BCG was added to each well at an MOI of 10 (bacteria
per cell) in 200 μl of medium. The bacteria were co-incubated with the cells for 30 min, washed
twice with PBS to remove extracellular bacteria and medium plus 200 μg/ml amikacin added
for 2 h at 37°C to select for intracellular bacteria. The cells were then stained with 10 μg/ml
DAPI in PBS by incubation for 5 minutes at room temperature, washed twice with PBS and
fixed in 4% paraformaldehyde in PBS for 30 min at room temperature. After washing with PBS
the slides were dried and mounted for viewing by confocal fluorescent microscopy.
Cryosections of lungs from infected mice for microscopy. Lungs were removed from
intratracheally infected mice, washed with PBS twice, and fixed with 4% paraformaldehyde for
24 h. The lungs were then washed with PBS twice and transferred into 30% sucrose until the
lungs sank. Lung tissue was placed in the cryomold, overlaid with O.C.T. compound (Sakura
Finetek USA Inc.), oriented and frozen quickly on dry ice. Cryosectioning was conducted with
the frozen lung tissue, and the lung tissues on the slides were then stained with DAPI. After
washing with PBS the slides were dried and mounted for viewing by confocal fluorescent
microscopy.
Statistical Analyses
The significance of the results was determined using the Student’s t-test or ANOVA, as appro-
priate. P values of< 0.05 were considered significant. In figures,  represents P<0.05;  repre-
sents P<0.01; and  represents P<0.001.
Results
1. tdTomato is the brightest fluorescent protein expressed by
mycobacteria in culture
Six FPs, tdTomato, mCherry, mPlum, mKate, Katushka and Keima, were cloned intoM. smeg-
matis, andM. bovis BCG downstream from a mycobacterial Hsp60 promoter. The fluorescent
signal was measured under the optimal excitation and emission wavelengths for each FP (tdTo-
mato: ex: 530 nm, em: 590 nm; mCherry: ex: 570 nm, em: 620 nm; mPlum, mKate, Katushka:
ex: 570 nm, em: 650 nm; and Keima: ex: 485 nm, em: 620 nm). Absorbance at 600 nm was mea-
sured for each strain to estimate bacterial numbers present. The brightness of each strain was
Fluorescent Proteins in Tuberculosis
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calculated by dividing relative fluorescence units of the strain by its optical density (OD) at 600
nm (Fig 1A). In both BCG andM. smegmatis, tdTomato was the brightest FP among the
selected FPs, followed by mCherry, mPlum, Katushka, mKate, and Keima.
We evaluated the impact of signal interference due to mammalian tissue by comparing
tdTomato and mCherry in Eppendorf tubes filled withM. smegmatis expressing Hsp60-tdTo-
mato or Hsp60-mCherry, and covering the tubes with different thicknesses of sliced ham.
These eppendorf tubes covered with sliced ham were then imaged to evaluate the relative fluo-
rescent signal displayed by each strain (S1 Fig).M. smegmatis expressing tdTomato was
5.6-fold brighter than the one expressing mCherry when using the same number of CFU.
The tdTomato and mCherry were then cloned under expression from a L5 promoter and
compared with strains expressing tdTomato or mCherry from the Hsp60 promoter. The
strains expressing FPs from the L5 promoter are brighter than the ones using the Hsp60 pro-
moter, when fluorescence was measured with a multimode reader (Fig 1B).
Fig 1. In vitro comparison of the brightness among different fluorescent protein-expressingmycobacterial strains. A. Comparison of the brightness
among different fluorescent protein expressing mycobacterial strains in culture medium. Different fluorescent protein expressingM. bovis BCG strains were
cultured in MOADmedium to OD600 0.5~1, and then the fluorescent signal of them were detected with a multimode reader at the optimal wavelength
condition for each FP. For each FP expressing strain, fluorescence signal was calculated by subtracting the background fluorescence of the strain carrying
the backbone vector for the FP. The Y-axis value was calculated mean of fluorescence of triplicates divided by their OD at 600 nm. The error bars are
standard deviations. One-way ANOVA test was conducted for assessing overall differences among groups, and Turkey’s multiple comparison tests were
applied to assess differences between two groups. * P<0.05; ** P<0.01; and *** P<0.001. B. Comparison of the brightness amongM. bovis
BCG-L5-tdTomato,M. bovis BCG-Hsp60-tdTomato,M. bovis BCG-L5-mCherry, andM. bovis BCG-Hsp60-mCherry. Five concentrations for each strain of
bacteria were loaded into a 96-well plate. The fluorescence of samples were compared by a multimode reader with 530 nm excitation and 590 nm emission
wavelengths for tdTomato; 570 nm excitation and 620 nm emission wavelengths for mCherry. Y-axis is in log scale. Data represent one of at least three
independent replicate experiments. The error bars are standard deviations.
doi:10.1371/journal.pone.0149972.g001
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2. Mycobacterial CFU can be estimated by fluorescence in vitro
We evaluated the ability to quantify bacterial CFUs using the fluorescent signals from the FP
expressing strains. This was accomplished by making dilutions of the bacteria and loading
100 μl of each concentration into a 96-well plate. The fluorescence from the four FP expressing
strains correlated very well with bacterial CFUs, R2 = 1 for L5-tdTomato and L5-mCherry; and
R2 = 0.999 for Hsp60-tdTomato and Hsp60-mCherry, indicating that we can accurately esti-
mate bacterial CFU with fluorescence.
The multimode reader could detect8,000 CFU of BCG-L5-tdTomato and
BCG-Hsp60-tdTomato (Fig 1B), but it could not detect the two mCherry strains at the same
CFU. BCG-L5-mCherry could be detected at40,000 CFU, while BCG-Hsp60-mCherry could
be detected at200,000 CFU.
Mycobacteria expressing tdTomato and mCherry from the two promoters were compared
during infection of mammalian macrophages. J774 A.1 macrophage cell line was infected with
the four FP expressingM. bovis BCG strains at five different multiplicities of infection (MOI)
(Fig 2). The fluorescent signals from the intracellular BCG strains were measured with a multi-
mode plate reader. Again, tdTomato expressing strains showed higher sensitivity, and strains
with the L5 promoter for FPs displayed higher fluorescence than did the strains expressing the
reporter from the Hsp60 promoter. The fluorescence levels from the four strains increased as
the MOIs went higher (L5-tdTomato, R2 = 0.90; Hsp60-tdTomato, R2 = 0.94; L5-mCherry, R2
= 0.92; Hsp60-mCherry, R2 = 0.93), which should represent a quantitative measure of intracel-
lular CFUs. These observations demonstrate that fluorescence from these strains could be used
to accurately estimate intracellular bacterial numbers.
3. Comparison of fluorescence from mycobacteria expressing FPs
during subcutaneous infection in mice
To select the best FP expressing strain for imaging in mammalian tissues, we conducted subcu-
taneous infections in mice. This model allowed us to compare fluorescence detected from dif-
ferent doses of bacteria, and/or different strains on the same mouse, thus background auto
fluorescence is well normalized.M. bovis BCG L5-tdTomato, Hsp60-tdTomato, L5-mCherry,
and Hsp60-mCherry were subcutaneously inoculated into BALB/c mice. The fluorescent sig-
nals were evaluated using epi-illumination imaging and optimal excitation and emission wave-
lengths for tdTomato and mCherry, respectively. Images were analyzed by spectral unmixing
to separate FP specific signal from autofluorescence in the animals (Fig 3). Detailed imaging
protocols are described elsewhere [37]. The BCG strain carrying the plasmid backbone without
a FP was used as a negative control in each mouse. At the same CFU, the BCG-L5-tdTomato
strain displays higher fluorescence than the BCG-Hsp60-tdTomato strain; and tdTomato
expressing strains display significantly higher fluorescence than mCherry expressing strains.
Imaging allows detection of106 CFU of both BCG-L5-tdTomato and BCG-Hsp60-tdTomato
strains in mice after subcutaneous inoculation by epi-illumination imaging. We chose the
L5-tdTomato strain for future experiments, because it showed the highest fluorescence at optimal
excitation and emission wavelengths after adjusting for bacterial numbers, in vitro and in vivo.
4. Expression of tdTomato did not affect mycobacterium growth in
culture medium, and the plasmids were stably carried by mycobacterial
strains
Expression of a foreign gene could be toxic to the host bacteria, and thus slows down bacterial
growth [19]. We evaluated whether expression of tdTomato affects mycobacterium growth.M.
Fluorescent Proteins in Tuberculosis
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bovis BCG strains with plasmids expressing tdTomato under L5 or Hsp60 promoter were com-
pared with strains carrying the vector plasmids alone. OD values at 600 nm for each strain was
Fig 2. Comparison of strains expressing fluorescent proteins under L5 and Hsp60 promoter expression in infected cells. J774A.1 cells were
infected with various multiplicities of infection (MOI) of the BCG strains expressing L5-tdTomato or Hsp60-tdTomato (A); L5-mCherry or Hsp60-mCherry (B).
Fluorescence was measured with a multimode reader with excitation wavelength 530 nm and emission wavelength 590 nm for tdTomato and excitation
wavelength 570 nm and emission wavelength 620 nm for mCherry. Value in Y-axis represents mean of fluorescence of triplicates divided by their OD at 600
nm. The error bars are standard deviations. Dotted lines represent background fluorescence from strains carrying backbone vectors. Data represent one of
at least three independent replicate experiments.
doi:10.1371/journal.pone.0149972.g002
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measured at each time point. There were no significant differences in growth curves among
L5-tdTomato or Hsp60-tdTomato strains and the strains carrying vectors alone (Fig 4A).
These observations suggest that expression of tdTomato does not affect bacterial growth.
Recombinant bacterial strains carrying plasmids require selective antibiotic in culture
media to ensure they are maintained. We evaluated stability of the tdTomato expressing plas-
mid in mycobacteria without the selective pressure of antibiotic.M. bovis BCG carrying
L5-tdTomato was cultured in MOAD with or without kanamycin, initially inoculated at OD600
0.005 and grown for 18 days. Fluorescence and OD600 during culture were measured. As
shown in Fig 4B–4E. The L5-tdTomato expressing strain cultured in medium without antibi-
otic had the similar levels of fluorescence and OD as cultured in medium with the selective
antibiotic for the entire 18-day of culture, which suggests the strain can carry the plasmid stably
for at least 18 days without antibiotics. Correlations between fluorescence and OD600 were ana-
lyzed within the range of OD600 from 0.05 to 1. With or without the selective antibiotic in
media, the fluorescence from this strain correlates well with bacterial numbers (OD600), sug-
gesting the measured fluorescence of this strain can be a good surrogate for bacterial numbers.
5. In vivo imaging mice intratracheally infected with mycobacteria
expressing tdTomato
We evaluated detection of the BCG-L5-tdTomato strain during pulmonary infections in mice.
BALB/c mice were intratracheally infected and imaged by transillumination at day 1 post infec-
tion. The intratracheal infection model allowed us to directly deliver precise doses of bacteria,
even higher doses than using aerosols are easily possible, into mouse lungs and to evaluate cor-
relation between in vivo detected fluorescence and bacterial CFU. Bacterial numbers in the
lungs were confirmed by conventional CFU determination. The results are shown as Fig 5A.
Imaging can detect as low as 6.5 x 104 CFU of BCG-L5-tdTomato during pulmonary infection
using transillumination. The in vivo imaging results were verified with ex vivo imaging by epi-
illumination of lungs harvested from the same mice (Fig 5B). The fluorescence correlated well
with CFUs recovered after plating lung homogenates (R2 = 0.96, Fig 5C). The bacteria in lungs
were further confirmed by fluorescence confocal microscopy on cryosections from lung tissues
(Fig 5D).
6. Application of tdTomato expressing mycobacteria to evaluation of
anti-TB therapeutic efficacy
We are interested in whether FP expressing bacteria can speed TB research involved in evalua-
tion of candidate anti-TB therapeutic compounds. The BCG-L5-tdTomato strain was loaded
into 96-well plates and treated with rifampin (RIF) and isoniazid (INH). Fluorescence changes
over time were measured with a multimode reader (Fig 6) and fluorescent imager (S2 Fig) with
and without treatment over 96 hours. We found that in the untreated group fluorescence
increased as the bacteria replicate; whereas, the treated group displayed reduced fluorescence
over time. The difference in fluorescence between treated and untreated groups was significant
by 24 h treatment.
Fig 3. Comparison of brightness among BCG strains expressing tdTomato, or mCherry in subcutaneously infectedmice. A. Images of
subcutaneous infected mice withM. bovis BCG strains expressing L5-tdTomato, Hsp60-tdTomato, L5-mCherry, or Hsp60-mCherry. 108, 107, and 106 CFU
of bacteria were injected subcutaneously into BALB/c mice. Images were acquired by epi-illumination at day 1 post infection. B. The locations of the
injections were shown on the map. C. Quantitative analysis of the images. Four mice were infected with technical replicates of the same culture. Values in the
Y-axis represent mean of fluorescence for each dose of bacteria. The error bars are standard deviations. Data represent one of two independent replicate
experiments. One-way ANOVA test was conducted for assessing overall differences among groups, and Turkey’s multiple comparison tests were applied to
assess differences between two groups. * P<0.05; ** P<0.01; and *** P<0.001.
doi:10.1371/journal.pone.0149972.g003
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We also evaluated if tdTomato expressing mycobacterial strains can be applied to evaluation
of anti-TB therapy in vivo during pulmonary infections. BALB/c mice were intratracheally
infected with 107 CFU ofM. bovis BCG L5-tdTomato, treated with RIF and INH daily by i.p.,
and imaged at day 0, 2 and 6 post-treatment. Starting from day 2, the treated group displayed
reduced fluorescence in the lungs (Fig 7). These observations demonstrate that a tdTomato
expressing mycobacterial strain can be used to rapidly evaluate anti-TB therapeutic efficacy.
Imaging is more time efficient than the previously standard approach of using conventional
CFU plating methods to determine therapeutic efficacy.
7. The L5-tdTomato expressingM. bovis BCG strain carries more
tdTomato gene copies than the Hsp60-tdTomato strain
We investigated the reasons that theM. bovis BCG L5-tdTomato strain displays higher fluores-
cence intensity than the Hsp60-tdTomato strain. At first, protein levels present in the L5-tdTo-
mato and Hsp60-tdTomato strains were compared. Cell lysates of BCG-L5-tdTomato and
BCG-Hsp60-tdTomato were evaluated using 100 μg of total protein with a multimode plate
reader (Fig 8A). The L5-tdTomato strain had two- to three-fold higher fluorescence than the
Hsp60-tdTomato strain. We also compared these strains by Western analyses using antibody
against RFP for tdTomato and anti-GroEL2 as a control for protein levels. As shown in Fig 8B
and 8C, the tdTomato protein expressed from the L5 promoter is approximately two-fold
higher than the level expressed from the Hsp60 promoter. Quantitative real-time RT-PCR was
used to compare the transcript levels for the tdTomato gene expressed from the L5 and Hsp60
promoters. As shown in Fig 8D, the tdTomato transcript number when expressed from the L5
promoter is also less than two-fold higher than that expressed from the Hsp60 promoter. Sub-
sequently, gene copy numbers in the two strains were also compared with DNAs as templates
using real-time qPCR. Interestingly, the strain having L5 promoter had four-fold higher plas-
mid copy number than did the strain having Hsp60 promoter (Fig 8E). We conclude that the
higher fluorescence intensity of L5-tdTomato strain than the Hsp60-tdTomato strain is a result
of more plasmid copy numbers in the L5-tdTomato strain than in the Hsp60-tdTomato strain.
Interestingly, despite the four-fold higher copy number, only two-fold higher transcript and
proteins levels are observed, suggesting that higher protein levels are blocked.
Discussion
The slow growth ofM. tuberculosis has hindered research toward discovery and translational
development of novel anti-TB therapeutics and vaccines. Noninvasive in vivo imaging technol-
ogies are emerging for quantification of bacterial loads in animals and has the potential to
greatly accelerate TB research. We examinedM. bovis BCG strains expressing various FPs to
select an optimal FP and promoter to allow detection of mycobacteria in vitro and in vivo with
fluorescence imaging. Among the selected FPs, we found that tdTomato expressing strains dis-
play the greatest fluorescence as compared to other FP expressing strains. When expressed
from the L5 promoter, there is a higher level of expression of tdTomato than from the Hsp60
promoter. Interestingly, when we compared the plasmid DNA copy number between the two
Fig 4. Evaluation of plasmid stability and the absence of effects on bacterial growth. A. Growth curves forM. bovis BCG strains carrying L5-tdTomato,
Hsp60-tdTomato or the vector plasmids alone (no fluorescent protein expressed). B. Optical density (OD) of cultures at 600 nm in 7H9 media with (kan 25) or
without (no kan) 25 μg/ml kanamycin over 18 days of culture. C. Fluorescence changes of the strain in media with or without kanamycin over 18 days of
culture. D. Correlation between fluorescence and OD at 600 nm for the strain grown in medium without kanamycin. E. Correlation between fluorescence and
OD at 600 nm for the strain grown in medium with kanamycin. For correlation analyses, samples for OD600 within the range of 0.05–1 were selected. Data
represent one of at least three independent replicate experiments. Values in the Y-axis represent mean of fluorescence or OD values. The error bars are
standard deviations.
doi:10.1371/journal.pone.0149972.g004
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strains, the L5 promoter strain had a higher copy number for tdTomato, which is four-fold
higher than the copy number in the Hsp60 promoter strain. We speculate that tdTomato may
be somewhat toxic if overexpressed in the bacteria. Although the L5 promoter strain carries
more gene copies than the Hsp60 promoter strain, the L5 promoter strain only expresses
Fig 5. Imaging BALB/c mice infected intratrachealy withM. bovisBCG expressing L5-tdTomato. A. IVIS images of mice infected intratrachealy with the
L5-tdTomato expressing strain. Images were acquired by trans-illumination at day 1 post infection. B. Images of the lungs harvested from the infected mice at
day 1 post infection. Images were acquired by epi-illumination. Colony forming units (CFU) from plating dilutions on agar plates are indicated in the images.
C. Quantitative analysis of images of the infected mice and the correlation between fluorescence ratios and CFUs. Four mice were infected for each dose of
bacteria from technical replicates of the same culture. Data represents one of two independent replicate experiments. Value in Y-axis represents mean of
fluorescence for each dose of bacteria. The error bars are standard deviations. D. Fluorescent microscopy of lung cryosections from BCG-L5-tdTomato
intratracheally infected mice. Upper left: DAPI; upper right: tdTomato; lower left: merge DAPI and tdTomato; and lower right: merge DAPI, tdTomato and
phase). White bars represent 20 micrometers.
doi:10.1371/journal.pone.0149972.g005
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slightly higher tdTomato transcript numbers, minimizing the toxicity of tdTomato to the bac-
terium. To our knowledge, this is the first report of mechanisms responsible for fluorescence
intensity differences between FP-labeled bacteria that are due to FP copy number levels at the
protein, RNA and DNA level. The results provide insight into strategies for design and con-
struction of FP expressing vectors. To select FP for in vivo imaging, they must be examined not
only for brightness and excitation and emission wavelengths, but also for the maximal FP
expression levels possible in the particular bacterium carrying the construct.
As previously shown by Carroll et al [10] and Zelmer et al [14], the fluorescent signal in our
FP labeled bacteria correlates very well with bacterial numbers by CFU, suggesting that the
L5-tdTomato expressing strain can be used to quantify bacterial numbers in vitro and in vivo
immediately, allowing the potential to replace conventional CFU numeration for quantification
of bacterial numbers during infection. This tdTomato expressing strain also offers the opportu-
nity to more rapidly evaluate new TB therapeutic regimen in vitro and in vivo. As the lowest
number of bacteria can be detected with this method is 6.5X104 CFU in vivo, other methods
with better sensitivities should be applied when quantification of bacteria lower than this limit
is required in therapy efficacy evaluation.
Among all the selected fluorescent proteins, tdTomato displays the greatest fluorescence,
5.9-fold that of mCherry [33, 39]. The structure of tdTomato is a tandem dimer of mCherry
Fig 6. In vitro evaluation of anti-TB therapeutic efficacy using theM. bovisBCG L5-tdTomato strain. Fluorescence of treated or untreatedM. bovis
BCG L5-tdTomato strain was measured with a multimode reader. The initial CFU for the treated or untreated was 106. The treated group was given 64 ng/μl
rifampicin and isoniazid. At each time point, bacteria were loaded into a 96-well plates as quadruplicate samples for each group. The Y-axes represent mean
fluorescence for the quadruplicates. Data represents one of two independent replicate experiments. Error bars are standard deviations. Repeated Measures
Two-way ANOVA was performed to examine overall difference between the two groups (treated vs. untreated) through multiple time points. Comparison of
treated with untreated group was matched at each time point. P<0.01.
doi:10.1371/journal.pone.0149972.g006
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with a few single nucleotide changes [39]. Although tdTomato’s maximum excitation and
emission wavelength are lower than 600 nm, which is outside the “NIR window”, the sensitivity
for detection of tdTomato expressing mycobacteria is greater than that of mCherry expressing
mycobacteria in vivo. The greater brightness of tdTomato is the most likely explanation for this
difference. The brightness of tdTomato ensures that hemoglobin and water within mammalian
tissue only absorb a portion of the excitation light and emission signal.
Both luciferase and fluorescent protein labeled mycobacterial strains have been developed
for TB studies [10, 11, 13–19, 40]. Three of these reporter systems have been applied to in vivo
detection ofMtb infection in mice [11, 14, 18, 19]. The sensitivity of our tdTomato expressing
strain is similar to that using a luciferase expressing strain [11]. However, we have developed
another in vivo imaging strategy designated reporter enzyme fluorescence (REF), in which
mycobacteria are detected using a fluorogenic substrate for the mycobacterial beta-lactamase.
With a REF substrate, CNIR5, we can detect 104 CFU of mycobacteria in lungs of live mice
[12]. Both our tdTomato expressingM. bovis BCG strain and the luciferase expressingMtb
strain are somewhat less sensitive than REF imaging ofMtb infection in vivo. Unlike REF- and
luciferase-based imaging, imaging with FP expressing strains do not require administration of
a substrate, or time for the substrate to reach peak levels in tissues. These characteristics offer
the advantage that our FP reporter strains can be repeatedly imaged over very short periods of
time, without having to wait for clearance of previous imaging probes. If brighter fluorescent
proteins with longer excitation and emission wavelengths can be developed, the sensitivity of
imaging with FP expressing strains could reach that of REF technologies, but still would require
recombinant strains, which have their inherent limitations. These limitations could include the
inability to image clinical strains without recombinant modification, potential impacts on viru-
lence of pathogenic strains and potential toxicity due to overexpression of reporters.
Another imaging technique that does not require substrate uses the bacterial luxCDABE
operon, which includes both luciferase and luciferase substrate genes. Mycobacterial strains
expressing luxCDABE have been used to evaluate anti-TB therapy efficacies [15, 16, 18, 40]. It
has been reported that high level expression of luxD is toxic to mycobacteria, because luxD
encodes an acyl transferase involved in bacterial cell wall fatty acid modification [19]. This
explains why all mycobacterial whole lux-operon based strains developed to date have incorpo-
rated a single copy of the operon in the mycobacterial chromosome [15, 18, 19]. We did not
find that expression of tdTomato affected bacterial growth under laboratory culture
conditions.
We used strains carrying plasmids expressing multi-copy FP genes. It has been reported
that plasmids carrying FP in mycobacterial strains are stable over days to weeks [10]. Our
results demonstrate that the tdTomato expressing strain can stably maintain the plasmid for as
long as 18 days without antibiotic selective pressure, as has been shown by others previously
[10, 14]. This feature makes it suitable for long term in vitro and in vivo experiments, even
without administration of the antibiotic. Our ongoing studies are designed to ensure that
mycobacteria express these FPs in a more stable manner using single copy tdTomato and
mCherry expressing constructs that are site-specifically integrated into the mycobacterial
Fig 7. In vivo evaluation of anti-TB therapeutic efficacy using theM. bovis BCG L5-tdTomato strain. A. Images of infected mice treated or untreated
with anti-TB therapy. Mice were infected intratracheally withM. bovis BCG with L5-tdTomato and treated or untreated with anti-TB therapy (10 μg/g rifampicin
and isoniazid; intraperitoneal injection.). Images were acquired by trans-illumination at day 0, 2, and 6 post infection. B. Quantitative analysis of in vivo
images. C. Images of lungs harvested from the mice sacrificed at day 0, 2, and 6 post infection after in vivo imaging. Images were acquired by epi-
illumination. D. Quantitative analysis of images of harvested lungs. E. Colony forming units (CFU) in mouse lungs recovered from agar plating. Y-axis is in log
scale. There were four infected mice and one uninfected mouse per group per time point. Data represents two independent replicate experiments. Two-way
ANOVA was performed to examine overall difference between the two groups (treated vs. untreated) through multiple time points. Bonferroni post-hoc tests
have been performed between treated and untreated groups at each time point. * P<0.05; ** P<0.01; and ***P<0.01
doi:10.1371/journal.pone.0149972.g007
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chromosome, using a mycobacterial plasmid containing the phage attachment site attP and the
L5 integrase (int) gene from the mycobacteriophage L5 genome. These constructs integrate
tdTomato or mCherry into the mycobacterial chromosome via site-specific recombination of
the plasmid-borne attP site with the chromosomal attB site, as has been shown by others for
Fig 8. Comparison between L5-tdTomato and Hsp60-tdTomatoM. bovis BCG strains in protein levels, transcript numbers and gene copies of
tdTomato. A. Comparison of the fluorescence from supernatant of bacterial lysates betweenM. bovis BCG L5-tdTomato and Hsp60-tdTomato strains.M.
bovis BCG L5-tdTomato and Hsp60-tdTomato strains were grown until OD600 = 0.75. 10
6 bacteria/ml were ultrasonically lysed in 1x PBS with 0.1% Triton X-
100. After centrifugation, the supernatant from the samples was compared using a multimode reader with 530 nm excitation and 590 nm emission
wavelengths. B. Western Blotting to compare tdTomato protein levels expressed from an L5 promoter with that expressed from the Hsp60 promoter. The
strain carrying the Hsp60 vector was used as a negative control. Bacterial housekeeping gene GroEL2 was used as the loading control. C. Quantification of
relative band intensities in D by densitometry. D. Real time RT-PCR to compare transcripts of tdTomato expressed from the L5 promoter with transcripts
levels expressed from the Hsp60 promoter. E. Real time q-PCR to compare copy numbers of tdTomato expressing plasmid with the L5 promoter and that
carrying the Hsp60 promoter. Data represent one of three replicate experiments. Student’s t-test was performed to examine difference between the
L5-tdTomato and Hsp60-tdTomato strains in fluorescence of extracted protein, transcript numbers and gene copies. * represents P<0.05; and ** represents
P<0.01.
doi:10.1371/journal.pone.0149972.g008
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bioluminescent reporters [11, 19]. Although these strains carry single copy of fluorescent pro-
tein genes, it may not necessary lead to lower fluorescence than strains carrying more copies of
fluorescent protein genes. A previous study compared luminescence amongMtb strains carry-
ing higher copy, low copy, and single copy chromosomal luminescent genes, and revealed that
the highest luminescence was expressed in strains carrying single copy luminescent genes [19].
Similarly, another study comparedMtb strains expressing high and low copy of fluorescent
protein genes, and found that fluorescence from the higher copy strains were not higher than
that from lower copy strains [10]. With the strains carrying FPs in chromosome, long-term
animal or cell infection experiments could be conducted in the absence of plasmid selection.
In summary, in agreement with a previous study by others [14] we have demonstrated that
in vivo fluorescence imaging with FP-expressing mycobacterial strains can be used to quantify
bacterial load in animals, which, once more widely applied, could significantly accelerate TB
research, particular for analysis of novel therapies and during vaccine development.
Supporting Information
S1 Fig. Comparison of fluorescence ofM. smegmatis expressing Hsp60-tdTomato or
Hsp60-mCherry in tubes under sliced ham. This setup was used to optimize the imaging con-
ditions for detecting these two FP expressing strains. Each strain was loaded into eppendorf
tubes and imaged with an IVIS Lumina. Eppendorf tubes were covered with various layers of
sliced ham and imaged to assess the transmission properties of the fluorescent reporters when
scattered by mammalian tissue that contains hemoglobin (ham). Relative fluorescence ratios
are shown next to the sites of Eppendorf tubes. They were calculated by setting the sample with
the lowest fluorescence as a reference. The experiment was performed once.
(TIFF)
S2 Fig. Comparison of fluorescence levels between anti-TB therapy treated and untreated
groups. A. Images of INH+RIF treated and untreated BCG-L5-tdTomato strain in culture
medium at 96-h post-treatment. 106, 105, and 104 colony forming unites (CFU) were loaded
into 96-well plates. Images were acquired by reflective illumination and analyzed with spectral
unmixing. B. Quantitative analysis of A. Data represents one of at least three independent repli-
cate experiments. Two-way ANOVA was performed to examine overall difference between the
two groups (treated vs. untreated) through multiple CFU groups. Comparison of treated with
untreated group was matched at each CFU, P<0.001. Bonferroni post-hoc tests were per-
formed by comparison of treated group with untreated group at each CFU group.  represents
P<0.05; and  represents P<0.001.
(TIFF)
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